Retatrutide
GLP-1 Peptide · 10mg~20mg
China-based peptide supplier specializing in fast international fulfillment, wholesale vial supply, export packaging, and competitive global shipping rates.
Retatrutide wholesale supplier listing
Product overview
Wholesale Retatrutide peptide supply from MJT Peptides with public Janoshik verification, fast international shipping options, and low-cost box MOQ ordering.
MJT Peptides
Shipping lanes
Tracking information is provided within 24–72 hours after shipment dispatch.
Retatrutide
Overview
Retatrutide is an investigational synthetic peptide designed as a triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptor pathways. It is one of the most closely watched metabolic research compounds because it combines three incretin and energy-balance signalling pathways in a single molecule.
Molecular Class
Synthetic peptide / incretin-based triple hormone receptor agonist.
Mechanism
Retatrutide is designed to activate glucose-dependent insulinotropic polypeptide receptor, glucagon-like peptide-1 receptor, and glucagon receptor pathways. This combined receptor profile makes it different from single GLP-1 agonists and dual GIP/GLP-1 agonists.
Research Areas
- Obesity research
- Metabolic signalling research
- Type 2 diabetes research
- Liver-fat and MASLD research
- Appetite and satiety pathway research
- Cardiovascular risk-factor research
- Energy expenditure research
- Incretin pharmacology research
Research Status
Retatrutide remains an investigational compound in active clinical development. Lilly is studying it across several Phase 3 programs, including obesity, type 2 diabetes, sleep apnea, osteoarthritis, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease.
Market Demand
Global demand is driven by obesity, metabolic disease, GLP-1, and next-generation incretin research. China-based peptide manufacturers frequently list retatrutide in wholesale vial formats for international research buyers.
Retatrutide supplier questions
What is Retatrutide?
Retatrutide is a glp-1 peptide supplied by MJT Peptides, featuring public Janoshik-linked batch testing references, 10mg~20mg vial configurations, and Guangdong, China fulfilment support for research-use laboratory workflows.
What MG configurations are available for Retatrutide?
Retatrutide is available in 10mg~20mg configurations depending on MJT Peptides inventory availability and supplier stock levels.
Has Retatrutide undergone batch testing?
MJT Peptides is a peptide supplier operating from Guangdong, China, offering Retatrutide batches with public laboratory testing references and international fulfilment support.
Who supplies this Retatrutide?
MJT Peptides is a Guangdong, China-based peptide supplier offering Retatrutide batches with public laboratory testing references and international fulfilment support.
What is the MOQ for Retatrutide?
The current minimum order quantity for Retatrutide is 10 vials / 1 box.
Is Retatrutide intended for human use?
Retatrutide is supplied strictly for laboratory research use only and is not sold for human consumption, medical use, or self-administration.